CIPLA vs ZYDUSLIFE — stock comparison
Cipla Ltd (CIPLA) vs Zydus Lifesciences Ltd (ZYDUSLIFE): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, ZYDUSLIFE grades higher (B 63 vs B+ 74). Not investment advice.
1-year price performance — higher line = stronger return
■ CIPLA -10.6%■ ZYDUSLIFE +16.7%Past year, both rebased to 100
| CIPLA | ZYDUSLIFE | |
|---|---|---|
| Traddx grade | B (63) | B+ (74) |
| Price | ₹1,343.00 | ₹1,160.00 |
| Today | 0.67% | 1.89% |
| P/E | 30.30 | 23.80 |
| ROE | 11.60% | 21.20% |
| Net margin | 16.98% | 11.82% |
| Debt / equity | 0.02 | 0.46 |
| 52-week high | ₹1,672.20 | ₹1,232.00 |
| 52-week low | ₹1,165.55 | ₹835.85 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open CIPLA live → Open ZYDUSLIFE live →